Lv3
240 积分 2023-07-12 加入
Abstract 3514: AZD6621: Improving the therapeutic index for prostate cancer T cell engagers with a next-generation CD8-guided format
19天前
已关闭
Immunological features of clear-cell renal-cell carcinoma and resistance to immune checkpoint inhibitors
2个月前
已完结
A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity
2个月前
已完结
Multiple myeloma
3个月前
已关闭
KGX105, a conditionally active prodrug of EGFRxCD3 T cell engager induces anti-tumor potency
4个月前
已完结
The prognostic and predictive role of HER2 amplification/overexpression and HER2 mutations in metastatic colorectal cancer treated with first-line chemotherapy plus bevacizumab/anti-EGFRs: An individual patient data pooled analysis of eight randomized trials
4个月前
已完结
Structure and interactions of the proteins from the contact system
8个月前
已完结
Incorporation of a repeated polypeptide sequence in therapeutic antibodies as a universal masking procedure: A case study of T cell-engaging bispecific antibodies
9个月前
已完结
皖公网安备34019202002308
